Trial intelligence / Profile preview

dTpa Booster Vaccine in Adults 10 Years After Previous Boosting

NCT00548171Phase 4Completed

Sponsor
GSK
Start
Nov 2007
Primary completion
Apr 2008
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) in diphtheria, Tetanus, pertussis, sponsored by GSK. Started Nov 2007; status: completed.

02

Drugs

Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)
03

Conditions

diphtheriaTetanuspertussis

Beyond the preview

Go deeper on NCT00548171.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00548171.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call